Comments

Estrella Immunopharma

Q: What sector and industry does Estrella Immunopharma (ESLAW) operate in?

Estrella Immunopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

ESLAWNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$0.092000

At close: Jul 29, 8:35 AM EDT

$0.100000

0.00808.70%

After Hours: Jul 29, 8:35 AM EDT

Estrella Immunopharma (ESLAW) Forecast

News Earnings Estrella Immunopharma (ESLAW) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Estrella Immunopharma (NASDAQ:ESLAW) Stock Quotes, Forecast and News Summary

Estrella Immunopharma Stock (NASDAQ: ESLAW) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 5.94K
Day Range	- - -
52 Wk Range	0.03 - 0.19
Market Cap	-
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	-
Days to Cover	10.73

Recent News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	-
Close	-
Volume / Avg.	0 / 5.94K
Day Range	- - -
52 Wk Range	0.03 - 0.19
Market Cap	-
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	-
Days to Cover	10.73

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Estrella Immunopharma (ESLAW) stock?

You can purchase shares of Estrella Immunopharma (NASDAQ:ESLAW) through any online brokerage.

View our list of the best stock brokerages

Who are Estrella Immunopharma (ESLAW) competitors?

Other companies in Estrella Immunopharma’s space includes: Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).

What is the forecast, or price target, for Estrella Immunopharma (ESLAW) stock?

There is no analysis for Estrella Immunopharma to provide a consensus price target.

What is the current price for Estrella Immunopharma (ESLAW)?

The stock price for Estrella Immunopharma (NASDAQ: ESLAW) is $0.1 last updated July 29, 2024 at 8:35 AM EDT.

Does Estrella Immunopharma (ESLAW) pay a dividend?

There are no upcoming dividends for Estrella Immunopharma.

When is Estrella Immunopharma (NASDAQ:ESLAW) reporting earnings?

Estrella Immunopharma does not have any upcoming earnings scheduled.

Is Estrella Immunopharma (ESLAW) going to split?

There is no upcoming split for Estrella Immunopharma.

What sector and industry does Estrella Immunopharma (ESLAW) operate in?

Estrella Immunopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.